Content related to Phase 3 Clinical Trial Shows Benefits of a New Treatment for Children With Congenital Adrenal Hyperplasia

Findings from the novel study suggest that congenital adrenal hyperplasia begins to affect brain development in the womb.

A CHLA clinical trial finds that N-acetylcysteine may be a promising next-generation therapy to reduce the risk of cisplatin-induced hearing loss.

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

A heart transplant can be the best option for children with end-stage heart failure. Heart failure from congenital heart disease is the top reason that children under one year of age need a transplant

The trial is studying a potential treatment for Dup15q and incorporates an EEG biomarker established by CHLA researchers.

A statistical analysis of the largest study cohort to date sheds light on improvements—and gaps—in post-relapse treatment for Acute Lymphoblastic Leukemia.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

Bariatric surgery is one part of a comprehensive CHLA program aimed at improving the long-term health of children and adolescents living with obesity.

Clinical trials bring new research to kids and adults. Why should adults and kids take part in clinical trials? Because everyone can benefit.